Transgenic animals as models for human disease

Transgenic animals, especially mice, have been used quite extensively as models for various human diseases. At first, the level of scientific inquiry was driven by the need to establish the model. In many cases, these models may be considered quite crude because of their limitations. More recently, transgenic models of disease have become more refined and are currently being used to study the pathological mechanisms behind the disease rather than to just provide a model of the disease. Using some examples from the recent literature, we will document the current level and complexity of inquiry using transgenic animals. New techniques and techniques that may prove promising will be discussed.

[1]  J. Simons,et al.  Transgenic livestock. , 2019, Journal of reproduction and fertility. Supplement.

[2]  P. Romeo,et al.  Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. , 1991, The EMBO journal.

[3]  C. Higgins,et al.  Cystic fibrosis mice have arrived! , 1992, Human molecular genetics.

[4]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[5]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[6]  Y. Hao,et al.  Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Petters,et al.  Transgenic Livestock - Review - , 1994 .

[8]  J. Whitsett,et al.  Transgenic models for study of pulmonary development and disease. , 1994, The American journal of physiology.

[9]  L. Bruijn,et al.  Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease , 1996, Neuropathology and applied neurobiology.

[10]  A. Harris,et al.  Towards an ovine model of cystic fibrosis. , 1997, Human molecular genetics.

[11]  M. Tso,et al.  A pathologic study of degeneration of the rod and cone populations of the rhodopsin Pro347Leu transgenic pigs. , 1997, Transactions of the American Ophthalmological Society.

[12]  A. Cideciyan,et al.  Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa , 1997, Nature Biotechnology.

[13]  A. Milam,et al.  Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. , 1998, Investigative ophthalmology & visual science.

[14]  J. Kong,et al.  Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.

[15]  B. Sauer.  Inducible gene targeting in mice using the Cre/lox system. , 1998, Methods.

[16]  H. Westphal,et al.  Use of the Cre/lox Recombination System to Develop a Non-lethal Knock-in Murine Model for Osteogenesis Imperfecta with an α1(I) G349C Substitution , 1999, The Journal of Biological Chemistry.

[17]  R. Boucher,et al.  Pathophysiology of gene-targeted mouse models for cystic fibrosis. , 1999, Physiological reviews.

[18]  S. Orkin,et al.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Lobe,et al.  Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.

[20]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[21]  T. Aleman,et al.  Retinal Rod Photoreceptor–Specific Gene Mutation Perturbs Cone Pathway Development , 1999, Neuron.

[22]  M. Sakaguchi,et al.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. , 2000, Science.

[23]  T. Aleman,et al.  Optical coherence tomography (OCT) abnormalities in rhodopsin mutant transgenic swine with retinal degeneration. , 2000, Experimental eye research.

[24]  J. Kong,et al.  Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis , 2000, Neuroscience Letters.

[25]  G. Stamatoyannopoulos,et al.  Genetic correction of sickle cell disease: Insights using transgenic mouse models , 2000, Nature Medicine.

[26]  Krzysztof P Bobinski,et al.  Seeing is believing: Non‐invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography , 2000, Journal of neuroscience research.

[27]  I. Nir,et al.  Expression of Bcl-2 Protects against Photoreceptor Degeneration in retinal degeneration slow (rds) Mice , 2000, The Journal of Neuroscience.

[28]  C. Ware,et al.  Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene. , 2000, Genetics.

[29]  C. Sigmund,et al.  Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. , 2000, Stroke.

[30]  R. S. Williams,et al.  Transgenic animals in integrative biology: approaches and interpretations of outcome. , 2000, Journal of applied physiology.

[31]  C. Sigmund,et al.  Transgenic models as tools for studying the regulation of human renin expression , 2000, Regulatory Peptides.

[32]  H. Li,et al.  Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[34]  B. Shastry.  Gene disruption in mice: Models of development and disease , 1998, Molecular and Cellular Biochemistry.